Development of the Facial Skin Care Index: A Health-Related Outcomes Index for Skin Cancer Patients

Abstract

Pretesting afforded the opportunity to select items that optimally met our a priori conceptual and psychometric criteria for high data quality. Phase IV testing (validity and sensitivity before surgery and 4 months after Mohs micrographic surgery) for the 20-item FSCI is under way.